很高兴通知大家,Medix推出了新的重组艰难梭菌谷氨酸脱氢酶抗原(C. difficile GDH antigen)。该重组艰难梭菌 GDH 抗原可以作为艰难梭菌免疫检测中的对照抗原。MedixMABTMAnti-C. difficile GDH 单克隆抗体 (Medix货号:100714) 能够识别该重组艰难梭菌GDH 抗原。 产品信息: 目录号 产品描述 100714 Anti-C. difficile GD...
很高兴通知大家,Medix推出了新的重组艰难梭菌谷氨酸脱氢酶抗原(C. difficile GDH antigen)。该重组艰难梭菌 GDH 抗原可以作为艰难梭菌免疫检测中的对照抗原。MedixMABTMAnti-C. difficile GDH 单克隆抗体 (Medix货号:100714) 能够识别该重组艰难梭菌GDH 抗原。 产品信息: 目录号 产品描述 100714 Anti-C. difficile GD...
Quik Chek Complete for detection of Clostridium difficile in stools. C. Eckert, et. al. (Paris, FR)ECSMID: 29.04.2013 解决方案:新的检测指南 新的难辨梭菌 (C. difficile) 检测指南建议使用“两步法”方案,首先进行 GDH 酶联免疫法 (EIA) 分析,然后通过灵敏的毒素 EIA 分析确认阳性结果,最后进行培养...
新的难辨梭菌 (C. difficile) 检测指南建议使用“两步法”方案,首先进行 GDH 酶联免疫法 (EIA) 分析,然后通过灵敏的毒素 EIA 分析确认阳性结果,Z后进行培养试验以确定灵敏度。该检测方案能提供与“金标”培养 + 毒素检测类似的结果,但成本更低并且更加省时。 VIDAS® GDH & VIDAS® CD A&B 全新两步法指...
C.Difficile toxin A/B: 1.29%(n=2) in IBD group vs. 3.17%(n=10) non-IBD. Both patients in IBD group received gold-standard treatment vs. 60%(n=6) in non-IBD group. A chi-square test of independence was performed to examine the statistical significance of rates of positive GDH, ...
VIDAS C DIFFICILE GDH产品名称,K132010申请号,510k申请类型,BIOMERIEUX SA申请人,数据来源于药智数据美国上市器械数据库。
But if it’s negative, you can’t say that they don’t have C difficile. We do secondary tests to boost the overall accuracy. One of those secondary tests is the GDH assay. This assesses for an enzyme that is broadly released by Clostridium species, but not necessarily ...
产品名称:艰难梭菌(Clostridioides difficile)GDH单克隆抗体-标记产品货号:XFK058-2缓冲体系:10mM PBS,分子量:150KD储存条件:长期保存请于-20℃存放,短期保存(不超过15天)请于2-8℃存放。本产品仅供科研实验用,不做其它用途! 采购度:503分享到:标签:艰难梭菌(Clostridioides difficile)GDH单克隆抗体-标记 ...
and NAATs. A singular test lacks sufficient informativeness, thus necessitating a 2-step, sequential testing approach.[38]In the diagnostic process, the primary focus is detecting the presence ofC difficileantigen, achieved through either GDH testing for glutamate dehydrogenase produced byC difficileor ...
摘要: This page describes important issues regarding health care worker safety and cross-patient infection control related to the risk of C. difficile in health care facilities DOI: http://www.labour.gov.on.ca/english/hs/pubs/ib_c-difficile.php 收藏...